Complete Guide to Oxacillin Neonatal Pharmacokinetics
Overview
Oxacillin Neonatal is a Small Molecule used in the Infectious Disease therapeutic area. It is indicated for MSSA Infections (Neonates). Interactive oxacillin population pharmacokinetic simulator for neonates. Explore weight-based and age-based PK variability using published PopPK models.
Mechanism of Action
Oxacillin Neonatal exerts its pharmacological effect by targeting PBP. As a Small Molecule, it modulates this target to achieve therapeutic efficacy in MSSA Infections (Neonates). Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
The following parameters are derived from published PopPK models for Oxacillin Neonatal:
| Parameter | Value |
|---|---|
| v | 1.87 L × (WT/3.4) |
| cl | 1.01 L/h × (WT/3.4)^0.75 × (PNAD/36)^0.433 |
| pdTarget | fT>MIC 100% |
| proteinBinding | 90% |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Oxacillin Neonatal is administered via the IV route. Intravenous administration provides 100% bioavailability and allows precise control of drug exposure. Infusion duration and rate can significantly impact peak concentrations.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Infectious Disease therapeutic area, for the treatment of MSSA Infections (Neonates), understanding the pharmacokinetics of Oxacillin Neonatal is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Oxacillin Neonatal pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Oxacillin Neonatal PK Simulator
Explore Oxacillin Neonatal pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Oxacillin Neonatal?
The elimination half-life of Oxacillin Neonatal depends on patient-specific factors. Use our interactive Oxacillin Neonatal PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Oxacillin Neonatal administered?
Oxacillin Neonatal is administered via the IV route. It is indicated for MSSA Infections (Neonates). As a Small Molecule, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Oxacillin Neonatal?
Key pharmacokinetic parameters for Oxacillin Neonatal include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Oxacillin Neonatal dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Oxacillin Neonatal PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.